PPP1CB and cardiomyopathy: In the present study, we investigated whether heart-failure-inducible inhibition of PP1β by AAV9-mediated shRNA gene transfer is beneficial for preventing heart failure progression in muscle LIM protein-deficient (MLPKO) mice cardiomyopathy.